| CRO Services |
|
China CRO services has experienced the boom in the last few years, because pharmaceutical and medical device industries in Western countries are plagued by the rising cost and the declining productivity of drug development. Partnering with Contract Research Organizations (CROs) to lower the drug development cost has been popular with pharmaceutical companies in the western countries. As a result, the number of drug development projects outsourced to Chinese CROs by western pharmaceutical companies also increased substantially in the recent years. Today, the services that Chinese CROs can offer are quite extensive, which include the synthesis of API, chemical intermediates, safety and efficacy test, toxicological pathology, pre-clinical and clinical research. Although the CRO industry in China is still at its infancy, it shall continue to grow rapidly in the coming years.
Our CRO service team consists of the industrial experts who have many years’ experience in research and development and clinical trial study in Chinese and the U.S. pharmaceutical industry, and has strong technical background and in-depth knowledge about the CRO services. Working with our affiliates and the CRO firms that have partnerships with us, we can help our client achieve its business objective effectively.
The scope of our CRO service includes:
|
| < Prev | Next > |
|---|
Service Activities
Industrial News
- China Aoxing Pharmaceutical Company Receives Government Approval for Increased Ownership of its Main
- Reform to target hefty medicine costs
- China to develop traditional medicine vigorously
- Novartis to move Indian R&D operations to China: Financial Times
- India and China competing on pharma potential